Acelyrin Inc (NASDAQ:SLRN) shares, rose in value on Friday, March 28, with the stock price down by -1.52% to the previous day’s close as strong demand from buyers drove the stock to $2.60.
Actively observing the price movement in the last trading, the stock closed the session at $2.64, falling within a range of $2.55 and $2.64. Referring to stock’s 52-week performance, its high was $7.25, and the low was $1.85. On the whole, SLRN has fluctuated by 1.56% over the past month.
With the market capitalization of Acelyrin Inc currently standing at about $261.84 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-18.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that SLRN’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of SLRN currently trading nearly -2.52% and 11.20% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 50.38, while the 7-day volatility ratio is showing 5.47% which for the 30-day chart, stands at 5.14%. Furthermore, Acelyrin Inc (SLRN)’s beta value is 1.07, and its average true range (ATR) is 0.14.
A comparison of Acelyrin Inc (SLRN) with its peers suggests the former has fared considerably weaker in the market. SLRN showed an intraday change of -1.52% in last session, and over the past year, it shrunk by -60.90%%.
Data on historical trading for Acelyrin Inc (NASDAQ:SLRN) indicates that the trading volumes over the past 10 days have averaged 0.7 and over the past 3 months, they’ve averaged 2.21 million. According to company’s latest data on outstanding shares, there are 100.45 million shares outstanding.
Nearly 27.51% of Acelyrin Inc’s shares belong to company insiders and institutional investors own 76.07% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 4.68 million shares as on 2025-03-14, resulting in a short ratio of 1.78. According to the data, the short interest in Acelyrin Inc (SLRN) stood at 505.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 4.72 million. The stock has fallen by -17.20% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the SLRN stock heading into the next quarter.
